latest guidelines for treating chronic obstructive pulmonary disease
September 2003
The Canadian Thoracic Society just released the latest guidelines for treating chronic obstructive pulmonary disease.
These guidelines provide some important new recommendations.
Tiotropium (Spiriva) is now recommended for patients who don't improve on ipratropium (Atrovent).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive